Brief: Merus NV To Pay Genmab $240 Million Termination Fee Under Certain Conditions If Deal Falls Through - SEC Filing

Merus NV

29/09/2025 14:18

Sept 29 (Reuters) - SEC Filing:

MERUS NV: IF DEAL IS TERMINATED UNDER SOME CIRCUMSTANCES, CO TO PAY GENMAB A TERMINATION FEE OF $240 MILLION - SEC FILING

MERUS NV: IF DEAL IS TERMINATED UNDER SOME CIRCUMSTANCES,  GENMAB TO PAY REGULATORY TERMINATION FEE OF $416 MILLION TO CO- SEC FILING

Source text: [ID:n0001193125-25-221807]

Further company coverage: 2GH.F

 ((Reuters.Briefs@thomsonreuters.com;))